China Animal Health Market Size, Share, By Product (Biologics, Vaccines, Inactivated, diagnostics, instruments and devices, Pharmaceuticals, Anti-infectives, Analgesics, and Others), By Animal Type (Productive Animals, Swine, Fish, Poultry, Cattle, Sheep & Goats, Cats, Horses, and Others), China Animal Health Market Insights, Industry Trend, Forecasts to 2035.
Industry: HealthcareChina Animal Health Market Insights Forecasts to 2035
- China Animal Health Market Size 2024: USD 2989.9 Mn
- China Animal Health Market Size 2035: USD 8287.4 Mn
- China Animal Health Market CAGR: 9.71%
- China Animal Health Market Segments: Product and Animal Type

Get more details on this report -
The animal health market in China is experiencing a strong growth trend, which is mainly attributed to the expansion of the livestock sector, increasing pet ownership, and better awareness of disease prevention in animals and food safety. This market comprises veterinary medicines, vaccines, diagnostics, feed additives, and medical services for both production and pet animals. The growing demand for quality meat, milk, and eggs, and worries about animal-to-human diseases have together helped the animal health products uptake in China greatly.
Government initiatives are of utmost importance in developing the markets. The Chinese government has an active role in controlling animal diseases through the vaccination of animals, certain biosecurity practices, and the surveillance of animal epidemics like bird flu and African swine fever. The government's policies are also aimed at supporting the modern agricultural practices and upgrading the veterinary infrastructure, which in turn enhances the market.
Technological progress has been a major factor in reshaping the industry, with veterinary vaccines, molecular diagnostics, precision livestock farming, digital health monitoring, and biotechnology among the innovations leading to enhanced disease detection, treatment efficiency, and increased overall animal productivity in China.
Market Dynamics of the China Animal Health Market:
The livestock industry, which is the main source of animal protein, is the primary contributor to the growth of the China animal health market along with the rising trend of pet ownership in cities. Besides that, the possibility of using vaccines, diagnostics, and veterinary medicines has been increased by the outbreak of animal diseases from time to time, like African swine fever and avian influenza.
The growing knowledge of zoonotic diseases and food safety in general, supported by government vaccination and biosecurity programs, is another factor that contributes to market growth. Besides that, the ongoing improvement in animal farming methods and the increasing allocation of funds for veterinary healthcare facilities are pushing up the demand for new and advanced animal health solutions.
The adoption of advanced vaccines, diagnostics, and biologics is limited among small-scale farmers due to the high costs associated with them. Also, regulatory complexities, lengthy product approval processes, and selective access to veterinary services in rural areas are other factors that prevent market growth.
China Animal Health Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 2989.9 Million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR of 9.71% |
| 2035 Value Projection: | USD 8287.4 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 115 |
| Segments covered: | By Type, By Application |
| Companies covered:: | Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc. (Merck Animal Health), Elanco Animal Health, Virbac S.A., Ceva, Bimeda, Inc, Thermo Fisher Scientific, Vetoquinol S.A., Other, and Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
China Animal Health Market share is classified into product and animal type.
By Product:
The Chinese animal health market is classified by product into biologics, vaccines, inactivated, diagnostics, instruments and devices, pharmaceuticals, anti-infectives, analgesics, and others. Among these, the vaccine segment held the largest market share in 2024 and is predicted to grow at a remarkable rate in the future. The presence of livestock diseases, particularly African swine fever, avian influenza, and foot-and-mouth disease, is the main factor that determines the prevalence of the vaccination market and, thus, the demand for preventive healthcare products to a huge extent.
By Animal Type:
The China animal health market is divided by animal type into productive animals, swine, fish, poultry, cattle, sheep & goats, cats, horses, and others. Among these, the Swine segment accounted for the major market share in 2024 and is expected to grow at a significant rate of CAGR during the projected period. China is the biggest producer and consumer of pork in the world. The large economic value of swine stock, together with the continuous occurrence of diseases such as African swine fever and porcine reproductive and respiratory syndrome (PRRS), has resulted in a strong demand for vaccines, diagnostics, and therapeutics.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the China animal health market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in China Animal Health Market:
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc. (Merck Animal Health)
- Elanco Animal Health
- Virbac S.A.
- Ceva
- Bimeda, Inc
- Thermo Fisher Scientific
- Vetoquinol S.A.
- Other
Recent Developments in China Animal Health Market:
- In March 2025, New Ruipeng Pet HHHealthcare Group announced the acquisition of 60% stake in a Shanghai-based diagnostics lab, enhancing its capabilities in in-clinic testing services.
- In July 2025, Zoetis Inc. expanded its animal vaccine production facility in China to meet growing demand for livestock immunization and companion animal health solutions.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the China, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the China animal health market based on the following segments:
China Animal Health Market, By Product
- Biologics
- Vaccines
- Inactivated
- Diagnostics
- Instruments and Devices
- Pharmaceuticals
- Anti-infectives
- Analgesics and Others
China Animal Health Market, By Animal Type
- Productive Animals
- Swine
- Fish
- Poultry
- Cattle
- Sheep & Goats
- Cats
- Horses
- Others
Frequently Asked Questions (FAQ)
-
1.What is the base year and forecast period for the China Animal Health Market?The base year for the study is 2024, with historical data from 2020–2023. The market is forecast from 2025 to 2035.
-
2.What is the current and projected market size of the China Animal Health Market?The market was valued at USD 2,989.9 million in 2024 and is expected to reach USD 8,287.4 million by 2035, growing at a CAGR of 9.71% during the forecast period.
-
3.Which product segment dominates the China Animal Health Market?The vaccines segment dominated the market in 2024, driven by widespread livestock disease outbreaks, mandatory vaccination programs, and growing emphasis on preventive animal healthcare.
-
4.What are the key drivers of market growth?Key drivers include livestock sector expansion, rising pet ownership, government disease-control initiatives, and technological advancements in veterinary diagnostics and vaccines.
-
5.Who are the major players in the China Animal Health Market?Leading companies include Zoetis Inc., Boehringer Ingelheim, Merck Animal Health, Elanco, Virbac, Ceva, Bimeda, Thermo Fisher Scientific, and Vetoquinol S.A.
Need help to buy this report?